Envoy Medical, Inc. has entered into a Dismissal Agreement to resolve litigation with Atlas Merchant Capital SPAC Fund I LP, effectively ending the dispute without any financial payment by the company.
Key Details
- Agreement Date: The Dismissal Agreement was executed on October 6, 2026.
- Litigation Background: The lawsuit, filed in the Delaware Court of Chancery, stemmed from Atlas's allegation that it was improperly prevented from redeeming its shares of Class A Common Stock during Envoy Medical's September 2023 business combination.
- Resolution Terms: All of Atlas's claims will be dismissed with prejudice, and Envoy Medical is not required to make any payment to Atlas under the terms of the agreement.